PathogenDx Revenue and Competitors

Phoenix, AZ USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • PathogenDx's estimated annual revenue is currently $5.3M per year.(i)
  • PathogenDx's estimated revenue per employee is $155,000

Employee Data

  • PathogenDx has 34 Employees.(i)
  • PathogenDx grew their employee count by -8% last year.

PathogenDx's People

NameTitleEmail/Phone
1
CFOReveal Email/Phone
2
COOReveal Email/Phone
3
COO & Co-FounderReveal Email/Phone
4
CEO and Co-FounderReveal Email/Phone
5
Chief Scientific Officer & Co-FounderReveal Email/Phone
6
Director SalesReveal Email/Phone
7
CHIEF FINANCIAL OFFICERReveal Email/Phone
8
Training ManagerReveal Email/Phone
9
QMS SpecialistReveal Email/Phone
10
CEO/Co-FounderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M50%N/AN/A
#2
$0.9M60%N/AN/A
#3
$0.8M5-29%N/AN/A
#4
$5.3M340%N/AN/A
#5
$2.5M16-20%N/AN/A
#6
$1.1M70%N/AN/A
#7
$0.9M60%N/AN/A
#8
$2.2M2921%$58.2MN/A
#9
$171.9M1109-3%N/AN/A
#10
$0.9M60%N/AN/A
Add Company

What Is PathogenDx?

PathogenDx's(PDx) mission is to deliver disruptive testing technology and solutions to the botanical, food and agricultural testing markets that provide breakthrough simplicity, and cost-effectiveness, at an adaptable scale for both large and small testing facilities. Our technology will offer growers, processors, producers, consumers and ancillary services within the botanical, food and agricultural markets real-time data /information pertaining to the quality of their product. This will ensure a safer product from a human health standpoint, and protect crops preventing millions of dollars in losses from contaminated or spoiled product. We believe our technology and products will become the next “ Industry Gold Standard” in pathogen testing. We have made it simpler, faster and better. Our market research with numerous labs has shown that customers want a higher throughput, lower cost, and less cumbersome assay when it comes to pathogen testing and our mission is to serve and partner in their growth and success. We will accomplish this through the highest quality service, providing cutting edge solutions and a commitment to helping them meet their goals.

keywords:N/A

N/A

Total Funding

34

Number of Employees

$5.3M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PathogenDx News

2022-04-17 - The Need for More Stringent Testing in Cannabis

Milan Patel, CEO and co-founder of PathogenDx, shares insights on the current state of cannabis testing in the U.S., where we're falling...

2022-04-17 - EXCLUSIVE: PathogenDx's Cannabis Testing Technology Certified To Detect Bacterial & Fungal Species - Benz

PathogenDx announced that its next-generation cannabis and hemp testing technology, Detectx-Combined, has received an AOAC Performance...

2022-04-17 - Industry News: PathogenDx receives industry-first AOAC ...

PathogenDx, a U.S.-based biotechnology company specializing in molecular-based testing through widespread adoption of its advanced...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.3M340%N/A
#2
$3.9M3431%N/A
#3
$3.3M340%N/A
#4
$7.9M34-8%N/A
#5
N/A3413%N/A